نتایج جستجو برای: bare metal stents
تعداد نتایج: 219934 فیلتر نتایج به سال:
BACKGROUND Previous research suggests that the early benefit from revascularization with drug-eluting stents might diminish over time. METHODS We performed an extended analysis of a previously identified cohort of 6440 patients who underwent percutaneous coronary intervention between April 1, 2003 and March 31, 2005 using a prospective provincial clinical registry in Alberta, Canada. We compa...
AIMS Compared with bare metal stents (BMS), early generation drug-eluting stents (DES) reduce the risk of revascularisation in patients with ST-elevation myocardial infarction (STEMI) at the expense of an increased risk of very late stent thrombosis (ST). Durable polymer coatings for controlled drug release have been identified as a potential trigger for these late adverse events and this has l...
OBJECTIVE To compare the efficacy and safety of biodegradable polymer drug eluting stents with those of bare metal stents and durable polymer drug eluting stents. DESIGN Mixed treatment comparison meta-analysis of 258,544 patient years of follow-up from randomized trials. DATA SOURCES AND STUDY SELECTION PubMed, Embase, and Central were searched for randomized trials comparing any of the Fo...
AIMS To evaluate the effect of drug-eluting vs. bare metal stents for the treatment of coronary artery disease on overall, cardiac, and non-cardiac mortalities. METHODS AND RESULTS We conducted a systematic literature search to identify all randomized controlled trials comparing sirolimus or paclitaxel-eluting stents with bare metal stents and reporting mortality data after at least 1 year of...
Since its introduction, percutaneous coronary intervention (PCI) has been limited by 2 major factors: restenosis and vessel closure attributable to thrombosis. The use of coronary stents has had a marked beneficial impact on rates of restenosis.1,2 However, the vessel trauma that occurs during PCI induces platelet activation, and all currently available coronary stents are made of metal and are...
OBJECTIVES We sought to compare patient-oriented outcomes related to target vessel or nontarget vessel events for sirolimus-eluting stents (SES) versus bare-metal stents. BACKGROUND SES significantly reduce restenosis but the influence of reduced restenosis on overall patient-oriented outcome has not been reported. METHODS The study population included 1,057 patients randomized in the SIRIU...
1. Ribeiro EE, Ribeiro HB. Uso de stents farmacológicos na ‘vida real” : a importância dos registros. Arq Bras Cardiol. 2010; 95 (1): 131-4. 2. Kirtane AJ, Gupka A, Iyengar S, Moses JW, Leon MB, Applegate R, et al . Safety and eficacy of drug-eluting stents and bare metal stents: comprehensive meta-análisys of randomized trials and observational studies. Circulation. 2010; 119 (25): 3198-206. R...
The current technical step forwards in metallic stents (MS), bare metal stents (BMS) and drug-eluting stents (DES) respectively led interventional cardiologists to a rude therapeutic attitude, that even the most complex coronary lesions are being treated with angioplasty plus stents (TCA). About a third of all the patients with multivessel disease (MVD) in Europe are being treated with TCA inst...
DR. STONE: Welcome to this roundtable discussion. Today, we’ll be focusing on some of the advantages, disadvantages, and nuances of drug-eluting and baremetal stents in the practice of interventional cardiology. My name is Gregg W. Stone; I’m an interventional cardiologist and Professor of Medicine at Columbia University Medical Center and the Cardiovascular Research Foundation in New York City...
نمودار تعداد نتایج جستجو در هر سال
با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید